A functional haplotype in the 5' flanking region of the factor VII gene is associated with an increased risk of coronary heart disease

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 10, 2003, Pages 2179-2185

  Carew, J A ^a,b   Basso F , ^c   Miller, G J ^d   Hawe, E ^c   Jackson, A A ^a   Humphries, S E ^c   Baue, K A ^b  

^a VA BOSTON HEALTHCARE SYSTEM   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 7;

ALLELE; ARTICLE; BIOSYNTHESIS; CELL CULTURE; CORONARY ARTERY DISEASE; EXON; GENETIC POLYMORPHISM; GENETIC TRANSFECTION; GENETICS; GENOTYPE; HAPLOTYPE; HEART INFARCTION; HUMAN; INTRON; LIVER CELL CARCINOMA; MALE; METABOLISM; MIDDLE AGED; PROMOTER REGION; PROPORTIONAL HAZARDS MODEL; REPORTER GENE; RISK;

ALLELES; CARCINOMA, HEPATOCELLULAR; CELLS, CULTURED; CORONARY DISEASE; EXONS; FACTOR VII; GENES, REPORTER; GENOTYPE; HAPLOTYPES; HUMANS; INTRONS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PROPORTIONAL HAZARDS MODELS; RISK; TRANSFECTION;

EID: 3042784849     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00424.x     Document Type: Article

References (30)

1. Balleisen L, Bailey J, Epping P, Schulte H, van de Loo J. Epidemiological study on factor VII, factor VIII, and fibrinogen in an industrial population. Baseline data on the relation to age, gender, body weight, smoking alcohol, pill-using, and menopause. Thromb Haemost 1985; 54: 475-9.
2. Green F, Kelleher C, Wilkes H, Temple A, Meade T, Humphries S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals. Arterioscler Thromb 1991; 11: 540-6.
3. Hunault M, Arbini AA, Lopaciuk S, Carew JA, Bauer KA. The Arg353Gln polymorphism reduces the level of coagulation factor VII: in vivo and in vitro studies. Arterioscler Thromb 1997; 17: 2825-9.
4. Dell Acqua G, Iacoviello L, D'Orazio A, Di Bitondo R, Di Castelnuovo A, Donati MB. A polymorphic cluster in the 5' region of the human coagulation factor VII gene: detection, frequency, and linkage disequilibrium. Thromb Res 1997; 88: 445-8.
5. Van't Hooft FM, Silveira A, Tornvall P, Iliadou A, Ehrenborg E, Hamsten A. Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma FVII activity and mass concentration. Blood 1999; 93: 3432-41.
6. Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost 1996; 75: 567-72.
7. Pollak ES, Hung HL, Godin G, Overton GC, High KA. Functional characterization of the human factor VII5' flanking region. J Biol Chem 1996; 271: 1738-47.
8. Kudaravalli R, Tidd T, Pinotti M, Ratti A, Santacroce R, Margaglione M, Dallapiccola B, Bernardi F, Fortina P, Devoto M, Pollak ES. Polymorphic changes in the 5' lanking region of factor VII have a combined effect on promoter strength. Thromb Haemost 2000; 88:705-10.
9. Nederhand RJ. Linkage disequilibrium between factor VII polymorphisms. Thromb Haemost 1999; Suppl.: 1480(Abstract).
10. Carew JA, Barzegar S, Humphries SE, Miller GJ, Bauer KA. An extended haplotype in the 5' lanking region of the FVII gene is functional in elevating plasma factor VII levels. Thromb Haemost 2001; Suppl.: 2205(Abstract).
11. Meade TW, Mellows S, Brozovic M, Miller GJ, Chakrabarti RR, North WRS, Haines AP, Stirling Y, Imeson JD, Thompson SG. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 1986; ii: 533-7.
12. Junker R, Heinrich J, Schite H, Van der Loo J, Assman G. Coagulation factor VII and the risk of coronary heart disease in healthy men. Arterioscler Thromb Vasc Biol 1997; 17: 1539-44.
13. Smith FB, Lee AJ, Fowkes FGR, Price JF, Rumley A, Lowe GDO. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol 1997; 17: 3321-5.
14. Cooper JA, Miller GJ, Bauer KA, Morrissey JH, Meade TW, Howarth DJ, Barzegar S, Mitchell JP, Rosenberg RD. Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease. Circulation 2000; 102: 2816-22.
15. Iacoviello L, Di Castelnuovo A, De Knijff P, D'Orazio A, Amore C, Arboretti R, Kluft C, Benedetta-Donati M. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998; 338: 79-85.
16. Girelli D, Russo C, Ferraresi P, Olivieri O, Pinotti M, Friso S, Manzato F, Mazzucco A, Bernardi F, Corrocher R. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000; 343: 774-80.
17. Doggen DJM, Cats VM, Bertina RM, Reitsma PH, Vandenbroucke JP, Rosendaal FR. A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men. Thromb Haemost 1998; 80: 281-5.
18. Ardissino D, Mannucci PM, Merlini PA, Duca F, Fetiveau R, Tagliabue L, Tubaro M, Galvani M, Ottani F, Ferrario M, Corral J, Margaglione M. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 1999; 94: 46-51.
19. Miller GJ, Bauer KA, Barzegar S, Cooper JA, Rosenberg R. Increased activation of the haemostatic system in men at high risk for fatal coronary heart disease. Thromb Haemost 1996; 75: 767-71.
20. Miller GJ, Stirling Y, Esnouf MP. Factor VII-deficient substrate plasmas depleted of protein C raise the sensitivity of the factor VII bio-assay to activated factor VII: an international study. Thromb Haemost 1994; 71:38-48.
21. Von Clauss A. Gerinnungsphysiologische Shellnethode zur Bestim-mung des Fibrinogens. Acta Haematol 1957; 17: 237-46.
22. World Health Organization. Myocardial infarction community registers. Public Health Eur 1976; 5: 157-64.
23. Prineas RJ, Crow RS, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings. Standards and Procedures for Measure-ments and Classification. Boston: John Wright, PSC Inc., 1982.
24. Day I, Humphries SE, Richards S, Norton D, Reid M. High-throughput genotyping using horizontal polyacrylamide gels with wells arranged for microplate array diagonal gel electrophoresis (MADGE). Biotech-niques 1995; 19: 830-5.
25. Chakravarti A, Buetow KH, Antonarakis SE, Waber PG, Boehm CD, Kazazian HH. Nonuniform recombination within the human β globin gene cluster. Am J Hum Genet 1984; 36: 1239-58.
26. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-89.
27. Miller GJ, Cruickshank JK, Ellis LJ. Fat consumption and factor VII coagulant activity in middle aged men: an association between a dietary and thrombogenic coronary risk factor. Atherosclerosis 1989; 78:19-24.
28. Rao AK, Chouhan V, Chen X, Lun L, Boden G. Activation of the tissue factor pathway of blood coagulation during prolonged hypergylcemia in young healthy men. Diabetes 1999; 48: 1156-61.
29. Miller GJ, Stirling Y, Howarth DJ, Cooper JC, Green FR, Lane A, Humphries S. Dietary fat intake and plasma factor VII antigen concentration. Thromb Haemost 1995; 73: 893.
30. Meigs JB, Mittleman MA, Nathan DM, Toiler GH, Singer DE, Murphy-Sheehy PM, Lipinska I, D'Agostino RB, Wilson PWF. Hyperinsuline-mia, hyperglycemia, and impaired hemostatsis: the Framingham offspring study. JAMA 2000; 283: 221-8.